India - English - Central Drugs Standard Control Organization

excella - rabeprazole - vial - 20 - vial

India - English - Central Drugs Standard Control Organization

excella - rabeprazole,domperidone - tab - 20,10;mg - 10

India - English - Central Drugs Standard Control Organization

excella - rabeprazole,domperidone - cap - 20,30 - 10

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - aciclovir 25 mg/ml - solution for infusion - 25 mg/ml - active: aciclovir 25 mg/ml excipient: sodium hydroxide water for injection - dbl aciclovir intravenous infusion is indicated for: - treatment of herpes simplex infections. - prophylaxis of herpes simplex infections in immune-compromised patients. - treatment of varicella zoster infections. - the treatment of herpes simplex infections in the neonate. - prophylaxis of cmv infection in bone marrow transplant recipients. it has been shown that high dose intravenous aciclovir reduces the incidence and delays the onset of cmv infection. when high dose intravenous aciclovir is followed by 6 months treatment with high dose oral aciclovir (see prescribing information for oral aciclovir) mortality and the incidence of viraemia are also reduced.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - anastrozole 1mg;   - film coated tablet - 1 mg - active: anastrozole 1mg   excipient: hypromellose lactose monohydrate macrogol 300 magnesium stearate povidone sodium starch glycolate titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

alpha pharmaceuticals limited - baclofen 10mg - tablet - 10 mg - active: baclofen 10mg excipient: lactose monohydrate magnesium stearate sodium starch glycolate starch

New Zealand - English - Medsafe (Medicines Safety Authority)

medra & pharma services limited - baclofen 10mg - tablet - 10 mg - active: baclofen 10mg excipient: lactose monohydrate magnesium stearate maize starch sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - bicalutamide 50mg;   - film coated tablet - 50 mg - active: bicalutamide 50mg   excipient: lactose monohydrate magnesium stearate opadry white y-1-7000 povidone sodium starch glycolate - treatment of advanced prostate cancer in combination with gnrh (lhrh) agonist therapy or surgical castration. prevention of disease flare associated with the use of lhrh agonists.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 0.5%{relative} - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 0.5%{relative}

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 0.25% - solution for injection - 0.25 % - active: bupivacaine hydrochloride monohydrate 0.25%